Lv3
348 积分 2025-03-29 加入
The role of residual inflammatory risk and LDL cholesterol in patients with in-stent restenosis undergoing percutaneous coronary intervention
2个月前
已完结
Lipoprotein(a) and long-term in-stent restenosis after percutaneous coronary intervention
2个月前
已完结
Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention
8个月前
已完结
Meta-Analysis on the Efficacy of High-Dose Statin Loading Before Percutaneous Coronary Intervention in Reducing No-Reflow Phenomenon in Acute Coronary Syndrome
8个月前
已完结
Comparing Coronary Physiology Responses to Adenosine, Dobutamine, and Physical Exercise in Myocardial Bridges
8个月前
已完结
Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients
8个月前
已完结
Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)
8个月前
已完结
Association between triglyceride-glucose index combined with a body shape index and atherosclerotic cardiovascular disease risk varies by glycemic status: insights from the UK Biobank
9个月前
已完结
Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study
9个月前
已完结
Co-occurrence patterns and related risk factors of ischaemic heart disease and ischaemic stroke across 203 countries and territories: a spatial correspondence and systematic analysis
9个月前
已完结
皖公网安备34019202002308
